Subsidiary of Zhejiang Yongtai Technology Co. (002326.SZ) received the registration certificate for Lidocaine Prilocaine Cream drug.
Eternal Technology (002326.SZ) announced that its wholly-owned subsidiary, Binhai Meikang Pharmaceutical Co., Ltd., has recently received the "Drug Registration Certificate" for Lidocaine and Prilocaine Cream issued by the National Medical Products Administration.
Zhejiang Yongtai Technology Co., Ltd. (002326.SZ) announced that its wholly-owned subsidiary, Bin Hai Mei Kang Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the Lidocaine and Prilocaine Cream.
The announcement shows that the Lidocaine and Prilocaine Cream is a compound formulation of Lidocaine and Prilocaine, used for local anesthesia of the skin in the following situations: 1. Needle puncture, such as catheter insertion or taking blood samples; 2. Superficial surgical procedures, such as genital mucosa, before superficial surgery or infiltration anesthesia; leg ulcer cleaning/debridement surgery.
Related Articles

Shanghai Fosun Pharmaceutical (02196): Ketoprofen patches approved for clinical trials.

BEKE-W (02423) spent $3 million on December 11th to repurchase 513,000 shares.

Yunnan Energy New Material (002812.SZ) plans to increase the issuance to acquire 100% stake in Zhongke Hualian, improving the layout of advanced production capacity.
Shanghai Fosun Pharmaceutical (02196): Ketoprofen patches approved for clinical trials.

BEKE-W (02423) spent $3 million on December 11th to repurchase 513,000 shares.

Yunnan Energy New Material (002812.SZ) plans to increase the issuance to acquire 100% stake in Zhongke Hualian, improving the layout of advanced production capacity.






